[e-drug] Contents Prescrire International, Volume 10, Nr 55

E-drug: Contents Prescrire International, Volume 10, Nr 55
-------------------------------------------------------------------------

Prescrire international is the English language edition of la revue
Prescrire. It contains comprehensive evaluations of new drugs and
new indication, and reviews of adverse effects and therapeutic
interventions. Prescrire International is published six times a year.

Since January 2001, we have created Solidarity Subscription Rates
for low income countries, so that health professionals in such
countries can also use our source of independent information . The
Solidarity Rates apply to all subscribers who live in low income
countries, excluding pharmaceutical companies.

Contents of Prescrire International,
October 2001 Volume 10, N� 55

EDITORIAL
Press sources

NEW PRODUCTS
Venlafaxine (new indication)
Poorly established efficacy in generalised anxiety disorder
Mifepristone (new indication)
May help women undergoing vacuum aspiration of pregnancy
Sibutramine (new preparation)
No place in the management of obesity
News of Prescrire's Reps Monitoring Network
Pretences and off-label claims

ADVERSE EFFECTS
Low molecular weight heparin and pregnancy
Severe liver damage with leflunomide
Severe hepatitis due to Atrium�
Disopyramide: interactions with macrolide antibiotics
Urinary disorders on tramadol

REVIEWS
Choosing an anticoagulant during pregnancy
Unfractionated heparin is still the reference
Homeopathic arnica: just a placebo
Results of four placebo-controlled trials

OUTLOOK
Drugs agencies' websites under scrutiny

SHORTCUTS
Managing type 2 diabetes - Etonogestrel subcutaneous
implant - Lercanidipine

Prescrire International is financed by subscription fees only. We
cannot provide free subscriptions. Send us your name and address
if you want to receive a sample issue.
An annual subscription covers six issues and a five-year index.
Standard Subscription Rates :
Individuals = 85 USD (FF 600 or 91. 47 Euro)
students = 45 USD (FF 300 or 45. 73 Euro)
Commercial institutions = 210 USD (FF 1500 or 228. 67 Euro)
Solidarity Subscription Rates countries with GNP < 10,000 USD*:
Individuals = 35 USD (FF 250 or 38.11 Euro)
Students 21 USD (FF 150 or 27. 87 Euro)
Institutions = 85 USD (FF 600 or 91. 47 Euro) (pharmaceutical
companies excepted)

*The following countries are not eligible for Solidarity Subscription
Rates: Australia, Austria, the Bahamas, Belgium, Brunei, Canada,
Cyprus, Denmark, Finland, France, Germany, Greece, Hong Kong,
Iceland, Ireland, Israel, Italy, Japan, Kuwait, Liechtenstein,
Luxembourg, Monaco, the Netherlands, New Zealand, Norway,
Portugal, Qatar, Singapore, Spain, Sweden, Switzerland,
United Kingdom, United Arab Emirates, United States of America.

Prescrire International
BP 459
75527 Paris Cedex 11
Tel: 33 1 49 23 72 65
Fax: 33 1 48 07 87 32
E-mail: International@prescrire.org

--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Information and archive http://satellife.healthnet.org/programs/edrug.html
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.